Insider: Greenstreet Yvonne Chief Executive Officer - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 62,361 | 0 | 62,361 |
| Value | $27,837,950.40 | $0.00 | $27,837,950.40 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/18/2025 | DDS | 195 | Direct | COM | $450.92 | $87,929.40 | 62,361 |
| 08/18/2025 | DDS | 450 | Direct | COM | $449.92 | $202,464.00 | 62,556 |
| 08/18/2025 | DDS | 194 | Direct | COM | $447.98 | $86,908.12 | 63,006 |
| 08/18/2025 | DDS | 60 | Direct | COM | $455.82 | $27,349.20 | 56,221 |
| 08/18/2025 | DDS | 514 | Direct | COM | $451.99 | $232,322.86 | 61,847 |
| 08/18/2025 | DDS | 1,204 | Direct | COM | $454.84 | $547,627.36 | 56,281 |
| 08/18/2025 | DDS | 2,716 | Direct | COM | $454.04 | $1,233,172.64 | 57,485 |
| 08/18/2025 | DDS | 1,646 | Direct | COM | $452.96 | $745,572.16 | 60,201 |
| 06/02/2025 | DDS | 19,297 | Direct | COM | $306.00 | $5,904,882.00 | 48,948 |
| 05/30/2025 | DDS | 25,469 | Direct | COM | $304.00 | $7,742,576.00 | 55,119 |
| 05/30/2025 | DDS | 6,171 | Direct | COM | $306.00 | $1,888,326.00 | 48,948 |
| 03/03/2025 | DDS | 1,173 | Direct | COM | $243.36 | $285,461.28 | 100,271 |
| 03/03/2025 | DDS | 1,068 | Direct | COM | $242.37 | $258,851.16 | 101,444 |
| 03/03/2025 | DDS | 580 | Direct | COM | $245.26 | $142,250.80 | 98,900 |
| 03/03/2025 | DDS | 791 | Direct | COM | $244.41 | $193,328.31 | 99,480 |
| 03/03/2025 | DDS | 4 | Direct | COM | $248.36 | $993.44 | 98,635 |
| 03/03/2025 | DDS | 23 | Direct | COM | $247.35 | $5,689.05 | 98,639 |
| 03/03/2025 | DDS | 238 | Direct | COM | $246.18 | $58,590.84 | 98,662 |
| 02/28/2025 | DDS | 127 | Direct | COM | $239.18 | $30,375.86 | 87,039 |
| 02/28/2025 | DDS | 158 | Direct | COM | $236.51 | $37,368.58 | 87,289 |
| 02/28/2025 | DDS | 284 | Direct | COM | $240.32 | $68,250.88 | 86,755 |
| 02/28/2025 | DDS | 123 | Direct | COM | $238.33 | $29,314.59 | 87,166 |
| 02/28/2025 | DDS | 461 | Direct | COM | $241.51 | $111,336.11 | 86,294 |
| 02/28/2025 | DDS | 1,093 | Direct | COM | $242.44 | $264,986.92 | 85,201 |
| 02/28/2025 | DDS | 214 | Direct | COM | $244.11 | $52,239.54 | 84,547 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research